What sector does Vimta Labs Limited belong to?

Vimta Labs Limited operates in the Healthcare sector, specifically the Healthcare Research, Analytics & Technology industry, and is listed on the NSE.

What is the current share price of VIMTALABS?

As of the latest available quote, VIMTALABS traded at ₹631.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of VIMTALABS?

Vimta Labs Limited has a price-to-earnings (P/E) ratio of about 35.29. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of VIMTALABS?

The market capitalisation of Vimta Labs Limited is approximately ₹2,813 Cr.

Is Vimta Labs Limited profitable?

For its latest reported financial year, Vimta Labs Limited recorded a net profit margin of about 12.89%.

Does VIMTALABS pay a dividend?

Vimta Labs Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of VIMTALABS?

Vimta Labs Limited has a return on equity (ROE) of about 13.50%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of VIMTALABS?

Over the past 52 weeks, VIMTALABS has traded between a low of ₹376.05 and a high of ₹851.00.

Vimta Labs Limited

VIMTALABS NSE Healthcare Healthcare Research, Analytics & Technology

₹631.00

-0.62%

Delayed · cached 15 min

Fair value analysis

VIMTALABS

Vimta Labs Limited

₹634.95

Close used for this calculation

₹295.65Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

48/100

Profitability21/25

Returns6/25

Balance Sheet13/25

Efficiency8/25

Growth12/25

Average

Quality radar

Consensus fair value

₹295.65

Above FV

▼ -53.4% against the close used

Model range ₹154.39 – ₹488.91

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹154.39Fair value₹295.65Bull₹488.91

FairClose

52-week traded range

52W low ₹380.7052W high ₹825.05

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Vimta Labs Limited closed at ₹634.95, 114.8% above the consensus fair value of ₹295.65 drawn from 9 valuation models.

Financial DNA score 48/100 — Average. P/E of 46.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹183.80

-71.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹154.39

-75.7%

√(22.5 × EPS × BVPS)

EPS=9.26, BVPS=114.41 · outside Graham range (P/E 46.3, P/B 5.6) — asset-light, treat as a rough floor

Graham Formula

₹417.03

-34.3%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹359.75

-43.3%

EPS × 38.85x (sector P/E)

EPS=9.26, Sector P/E=38.85x

Peter Lynch (PEG)

₹223.17

-64.9%

EPS × Growth% (PEG = 1 is fair)

EPS=9.26, g=24.1%

EV/EBITDA

₹488.91

-23.0%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=1.21B

Book Value (P/B)

₹214.51

-66.2%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=114.41, ROE=13.5%, g=6%, r=10%

Reverse DCF

₹634.95

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 23.9% | Historical: 24.1%

Margin of Safety

₹209.06

-67.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=278.74, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer